Tag Archives: Vivus

Illumina Inc. (NASDAQ:ILMN) Down to Knees after Roche Offer Refused – ILMN, LIFE, LMNX, VIVUS, VVUS, PFE, DNDN, HLF, SQNM

Posted on January 7, 2013 by Geoff Noir

Illumina Inc. (NASDAQ:ILMN)plunged almost 8.5% in premarket session on Monday following Roche Holding AG Chairman Franz Humer reported in an interview that the firm does not intend to purchase the gene sequencing expert.

Illumina(ILMN) is certainly off the table, Humerreported …

Posted in Healthcare, Latest Headlines | Tagged Dendreon, DNDN, Herbalife, HLF, Illumina, ILMN, LIFE, Life Technologies, LMNX, Luminex, NASDAQ:DNDN, NASDAQ:ILMN, NASDAQ:LIFE, NASDAQ:LMNX, NASDAQ:PPHM, NASDAQ:SQNM, NASDAQ:VVUS, NYSE:HLF, NYSE:PFE, Peregrine, PFE, Pfizer, Sequenom, SQNM, Vivus, VVUS | Comments Off

Emergent Biosolutions (NYSE:EBS) Issues FY 2012 Results; Revenue Misses Estimates – WPI, MYL, PPHM, VVUS, BSX, ILMN, SQNM, UNH

Posted on January 7, 2013 by Thomas Vedder

Emergent BiosolutionsInc (NYSE:EBS) on Monday reported its preliminary fiscal year 2012 financial results, projecting revenues slightly lower than Wall Street analysts’ forecasts. Biopharmaceutical Company also offered 2013 revenue outlook lower than forecasts.

The company projects net income in the range …

Posted in Healthcare, Latest Headlines | Tagged Boston Scientific, BSX, EBS, Emergent Biosolutions, Illumina, ILMN, MYL, Mylan, NASDAQ:ILMN, NASDAQ:MYL, NASDAQ:PPHM, NASDAQ:SQNM, NASDAQ:VVUS, NYSE:BSX, NYSE:EBS, NYSE:UNH, NYSE:WPI, Peregrine Pharmaceuticals, PPHM, Sequenom, SQNM, UNH, UnitedHealth, Vivus, VVUS, Watson Pharmaceuticals, WPI | Comments Off

Healthcare Sector Under Scrutiny; Questcor Pharmaceuticals (QCOR) Inks Deal to Acquire BioVectra while Synergy’s (SGYP) Plecanatide Achieves Key Goals – QCOR, SGYP, JNJ, SIGA, DNDN, VVUS

Posted on January 3, 2013 by Thomas Vedder

Investors reacted positively to the healthcare stocks on Wednesday. Key movement were seen in SIGA Technologies, Inc (NASDAQ:SIGA) and Dendreon Corporation (NASDAQ:DNDN) on percentage gainers side while VIVUS, Inc (NASDAQ:VVUS) was prominent stock on the decliners side.

Questcor Pharmaceuticals Inc …

Posted in Healthcare, Latest Headlines | Tagged Dendreon, DNDN, JNJ, Johnson, NASDAQ:DNDN, NASDAQ:QCOR, NASDAQ:SGYP, NASDAQ:SIGA, NASDAQ:VVUS, NYSE:JNJ, QCOR, Questcor, SGYP, SIGA, SIGA Technologies, Synergy, Vivus, VVUS | Comments Off

Salix Pharmaceuticals Ltd.’s (NASDAQ:SLXP) Gets FDA Approval for Fulyzaq – SLXP, GSK, WCRX, PFE, MRK, HLF, ABT, VVUS, WPI

Posted on January 2, 2013 by Thomas Vedder

The Food and Drug Administration has accepted the initial anti-diarrheal drug for HIV/AIDS patients, Salix Pharmaceuticals Ltd.’s (NASDAQ:SLXP) Fulyzaq.

The medicine, also called as crofelemer, is created to get rid of symptoms of noninfectious diarrhea in patients with HIV/AIDS on …

Posted in Healthcare, Latest Headlines | Tagged Abbott, ABT, GlaxoSmithKline, GSK, Herbalife, HLF, Merck, MRK, NASDAQ:SLXP, NASDAQ:VVUS, NASDAQ:WCRX, NYSE:ABT, NYSE:GSK, NYSE:HLF, NYSE:MRK, NYSE:PFE, NYSE:WPI, PFE, Pfizer, Salix Pharmaceuticals, SLXP, Vivus, VVUS, Warner Chilcott, Watson, WCRX, WPI | Comments Off

Coronado Biosciences (NASDAQ:CNDO) Picks Harlan Weisman as New Chairman and Chief Executive – ABT, BIIB, PFE, HLF, MRK, VVUS, WPI, HEB

Posted on January 2, 2013 by Geoff Noir

Coronado Biosciences Inc (NASDAQ:CNDO) reported on Wednesday that the company has appointed Harlan Weisman as its new chairman and chief executive officer.

Harlan Weisman recently worked for Johnson & Johnson (NYSE:JNJ), where he held numerous posts, and before that he …

Posted in Healthcare, Latest Headlines | Tagged Abbott Laboratories, ABT, BIIB, BiogenIdec, CNDO, Coronado Biosciences, HEB, HemispherxBioPharma, Herbalife, HLF, Merck, MRK, NASDAQ:BIIB, NASDAQ:CNDO, NASDAQ:VVUS, NYSE:ABT, NYSE:HLF, NYSE:MRK, NYSE:PFE, NYSE:WPI, NYSEAMEX:HEB, PFE, Pfizer, Vivus, VVUS, Watson Pharmaceuticals, WPI | Comments Off

Eli Lilly & Co. (NYSE:LLY) Pays Charges Over Bribery Issues – LLY, GSK, PFE, HMA, VVUS, JNJ, HLF, MRK, HEB

Posted on December 21, 2012 by Geoff Noir

Pharmaceutical company Eli Lilly & Co. (NYSE:LLY) was fined by the Securities and Exchange Commission because of violating the Foreign Corrupt Practices Act for inappropriate payments its subsidiaries made to foreign government representatives to capture millions of dollars of business …

Posted in Healthcare, Latest Headlines | Tagged Eli Lilly, GlaxoSmithKline, GSK, Health Management Associates, HEB, Hemispherx BioPharma, Herbalife, HLF, HMA, JNJ, Johnson, LLY, Merck, MRK, NASDAQ:VVUS, NYSE:GSK, NYSE:HLF, NYSE:HMA, NYSE:JNJ, NYSE:LLY, NYSE:MRK, NYSE:PFE, NYSEAMEX:HEB, PFE, Pfizer, Vivus, VVUS | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.